News | October 18, 2024
MedGenome completes 10 years in genomics in India
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Akums Drugs will undertake this development and commercialization in India
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
Subscribe To Our Newsletter & Stay Updated
